These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6121773)

  • 41. Phenytoin and transmitter release at the neuromuscular junction of the frog.
    Yaari Y; Pincus JH; Argov Z
    Brain Res; 1979 Jan; 160(3):479-87. PubMed ID: 33744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On facilitation of transmitter release at the toad neuromuscular junction.
    Balnave RJ; Gage PW
    J Physiol; 1974 Jun; 239(3):657-75. PubMed ID: 4152979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calmodulin and the transmitter release at the neuromuscular junction. Contradictory results obtained with trifluoperazine.
    Brănişteanu DD; Brănişteanu DD; Haulică I
    Physiologie; 1989; 26(4):261-6. PubMed ID: 2576879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ionic mechanism of post-tetanic potentiation at the neuromuscular junction of the frog.
    Weinreich D
    J Physiol; 1971 Jan; 212(2):431-46. PubMed ID: 4323307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mediator secretion in the proximal and distal portions of a nerve ending of the sartorius muscle in the frog].
    Zefirov AL
    Neirofiziologiia; 1983; 15(4):362-9. PubMed ID: 6137778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantal stores of excitatory transmitter in nerve-muscle synapses of crayfish evaluated from high-frequency asynchronous quantal release induced by veratridine or high concentrations of potassium.
    Finger W; Martin C
    Pflugers Arch; 1989 Aug; 414(4):437-42. PubMed ID: 2552397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantal parameters of transmission at the frog neuromuscular junction.
    Volle RL; Branisteanu DD
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):103-8. PubMed ID: 186720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dantrolene and the effect of temperature on the spontaneous release of transmitter at the frog neuromuscular junction.
    Publicover SJ; Duncan CJ
    Experientia; 1981; 37(8):859-60. PubMed ID: 6116612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of monovalent cations on the spontaneous transmitter release in the neuromuscular junction of toad in the presence of ethanol.
    Okada K
    Yonago Acta Med; 1969 Aug; 13(2):103-11. PubMed ID: 4313408
    [No Abstract]   [Full Text] [Related]  

  • 50. Evoked transmitter release at the frog neuromuscular junction in very low calcium solutions.
    Crawford AC
    J Physiol; 1973 May; 231(1):47P-48P. PubMed ID: 4351787
    [No Abstract]   [Full Text] [Related]  

  • 51. Increase in quantal transmitter release by calcium- and sodium-containing phosphatidylcholine liposomes [proceedings].
    Barenholz Y; Erulkar SD; Meiri H; Rahamimoff R
    J Physiol; 1978 Nov; 284():65P-66P. PubMed ID: 215759
    [No Abstract]   [Full Text] [Related]  

  • 52. Cation dependence of posttetanic potentiation of neuromuscular transmission.
    Misler S; Falke L; Martin S
    Am J Physiol; 1987 Jan; 252(1 Pt 1):C55-62. PubMed ID: 3492922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transmitter release in crayfish neuromuscular junction: comments on the article by Staggs et al. (1980).
    Parnas I; Dudel J
    J Neurobiol; 1982 Jan; 13(1):75-7. PubMed ID: 6120212
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of carbamazepine on nerve activity and transmitter release in neuroblastoma-glioma hybrid cells and the frog neuromuscular junction.
    Matsumoto Y; Enomoto K; Moritake K; Maeno T
    Cell Biol Toxicol; 1998 Jun; 14(3):191-8. PubMed ID: 9689492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presynaptic effects of d-tubocurarine on neurotransmitter release at the neuromuscular junction of the frog.
    Matzner H; Parnas H; Parnas I
    J Physiol; 1988 Apr; 398():109-21. PubMed ID: 2899171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmitter release in ouabain treated Mg(2+)--paralysed neuromuscular junctions.
    Brănişteanu DD; Proca B; Zaim R; Brănişteanu G; Volle RL
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(3):437-47. PubMed ID: 16296503
    [No Abstract]   [Full Text] [Related]  

  • 57. [Proceedings: Presynaptic origin of neuromuscular junction blocks in the frog through the substitution of sodium by lithium in the survival medium].
    Benoit PH; Audibert-Benoit ML
    J Physiol (Paris); 1973; 67(3):332A. PubMed ID: 4375187
    [No Abstract]   [Full Text] [Related]  

  • 58. [Analysis of polymodality in the distribution of latent periods and amplitudes of single-quantum synaptic potentials in the frog neuromuscular junction].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1983 Aug; 69(8):1015-22. PubMed ID: 6138284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Participation of different types of voltage-dependent calcium channels in evoked quantal transmitter release in frog neuromuscular junctions.
    Tsentsevitsky AN; Vasin AL; Bukharaeva EA; Nikolsky EE
    Dokl Biol Sci; 2008; 423():389-91. PubMed ID: 19213416
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclic GMP and protein kinase G inhibit the quantal transmitter release induced by protein kinase C.
    Brănişteanu DD; Popescu LM; Brănişteanu DD; Haulică ID
    Brain Res; 1988 Nov; 464(3):263-6. PubMed ID: 2850086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.